Shannon Strom

Shannon Strom currently serves as the Senior Vice President of Regulatory Affairs at Aerogen Pharma, leading regulatory and organizational development with expertise in drug/device combination biologics. Previously, Shannon held roles as Vice President and Head of Regulatory Affairs at Satsuma Pharmaceuticals, overseeing global regulatory strategies for combination products, and Senior Director of Regulatory Affairs at Pearl Therapeutics, where Shannon managed regulatory submissions for complex respiratory products. Additional experience includes positions at Roivant Sciences, Cato Research, and early roles contributing to regulatory strategies across various organizations. Shannon holds a PhD in Pharmacology from the University of North Carolina at Chapel Hill and a B.S. in Biology from Duke University.